Zevra Therapeutics (ZVRA) Revenue (2016 - 2025)
Historic Revenue for Zevra Therapeutics (ZVRA) over the last 9 years, with Q3 2025 value amounting to $26.1 million.
- Zevra Therapeutics' Revenue rose 60540.54% to $26.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.4 million, marking a year-over-year increase of 24462.73%. This contributed to the annual value of $23.6 million for FY2024, which is 1401.62% down from last year.
- Latest data reveals that Zevra Therapeutics reported Revenue of $26.1 million as of Q3 2025, which was up 60540.54% from $25.9 million recorded in Q2 2025.
- In the past 5 years, Zevra Therapeutics' Revenue registered a high of $26.1 million during Q3 2025, and its lowest value of $1.3 million during Q2 2022.
- Moreover, its 5-year median value for Revenue was $4.0 million (2022), whereas its average is $8.5 million.
- As far as peak fluctuations go, Zevra Therapeutics' Revenue tumbled by 8915.4% in 2022, and later surged by 60540.54% in 2025.
- Zevra Therapeutics' Revenue (Quarter) stood at $2.6 million in 2021, then decreased by 21.69% to $2.0 million in 2022, then soared by 538.97% to $12.9 million in 2023, then dropped by 7.03% to $12.0 million in 2024, then soared by 117.28% to $26.1 million in 2025.
- Its Revenue stands at $26.1 million for Q3 2025, versus $25.9 million for Q2 2025 and $20.4 million for Q1 2025.